Mesothelioma Clinical Presentation - )
Chest - December 1, 1999, by Raphael Bueno
Objectives: Clinical teaching of treatment for mesothelioma
Design: Case presentation
Setting: Postgraduate course
Patient: A 52-year-old man with chest pain
Interventions: Multimodality therapy consisted of surgery, intrapleural chemotherapy, chemotherapy, and ra... (Read More)
Pleuropneumonectomy in the Treatment of Malignant Pleural Mesothelioma - )
Chest - December 1, 1999, by Sean C. Grondin,
David J. Sugarbaker
Study objectives: Malignant pleural mesothelioma (MPM) is predominantly a local/regional disease that results in a survival time that ranges from 4 to 12 months without treatment. Single-modality therapy using surgery, chemotherapy, or radiotherapy alone is largely ineffe... (Read More)
Thoracoscopy - ): Window to the Pleural Space
Chest - November 1, 1999, by Henri G. Colt
Window to the Pleural Space
Thoracoscopy has provided chest physicians and surgeons with an opportunity to rethink their approach to patients with pleural and pulmonary disease. In this review, several methods pertaining to videothoracoscopic procedures are described ar... (Read More)
A lesson to be learnt: A word out of place
British Medical Journal - October 23, 1999, by Solomon Almond
Some two years ago we looked after a man in his late 40s who had had unremitting pleural pain for several weeks. His chest radiograph revealed marked pleural thickening in the distribution of his pain and he had a history of exposure to asbestos dust. We suspected mesothe... (Read More)
Advances in the Treatment of Malignant Pleural Mesothelioma - )
Chest - August 1, 1999, by Daniel H. Sterman,
Larry R. Kaiser,
Steven M. Albelda
Malignant pleural mesothelioma is a neoplasm that is commonly fatal and for which there are no widely accepted curative approaches. Mesothelioma is unresponsive to most chemotherapy and radiotherapy regimens, and it typically recurs even after the most aggressive attempts... (Read More)
SmallCaps Online LLC Announces Investment Opinion on Aronex Pharmaceuticals, Inc
Business Wire - July 29, 1999
NEW YORK--(BUSINESS WIRE)--July 29, 1999--
SmallCaps Online LLC Initiates Coverage of Aronex Pharmaceuticals,
Inc. With a BUY Recommendation
Visit SmallCaps Online's Web Site at www.SmallCapsOnline.com for
Detailed Report
SmallCaps Online LLC announced today tha... (Read More)
San Francisco Jury Awards $5.1 Million to Retired Navy Man With Lung Disease in Case Tried by Wartnick, Chaber, Harowitz, Smith & Tigerman
Business Wire - July 8, 1999
SAN FRANCISCO--(BUSINESS WIRE)--July 7, 1999--
In the largest verdict of its kind in San Francisco, a jury has awarded a 51-year-old veteran and his wife $5.1 million.
The San Francisco Superior Court jury on Tuesday found that the maker of asbestos-filled gaskets and... (Read More)
Finger Clubbing and a Lung Mass - )
Chest - June 1, 1999, by John D. Urschel,
Timothy M. Anderson,
Brian P. Whooley
(CHEST 1999; 115:1735-1737)
A 71-year old man complained of enlargement of A his distal phalanges. He did not have any other musculoskeletal complaints, and he denied pulmonary symptoms. He was a heavy smoker. Medical history was unremarkable. He did not have symptoms o... (Read More)
Occupational disease
British Medical Journal - May 22, 1999, by Nicola Cherry
Summary points
An understanding of the causes of occupational disease requires both good epidemiology and detailed knowledge of the nature of exposure and the susceptibility of those exposed
Concern about the effects of workplace exposures on male reproductive capacit... (Read More)
Risk Assessment of Lung Cancer and Mesothelioma in People Living near Asbestos-Related Factories in Taiwan
Archives of Environmental Health - May 1, 1999, by Ho-Yuan Chang,
Cheng-Ren Chen,
Jung-Der Wang
INVESTIGATORS HAVE copiously used risk assessment to bridge the intricate relationship between science and policy in the prioritization and control of hazardous materials, especially chronic health hazards and carcinogens.[1] Researchers have implemented four steps before... (Read More)
Risk Assessment of Lung Cancer and Mesothelioma in People Living near Asbestos-Related Factories in Taiwan
Archives of Environmental Health - May 1, 1999, by Ho-Yuan Chang,
Cheng-Ren Chen,
Jung-Der Wang
The common characteristics of the silicate minerals collectively known as asbestos are a fibrous structure and resistance to fire. Fabricated into corrugated or flat sheets, asbestos has been used as building material in a wide variety of structures, including many schools ... (Read More)
ALFACELL Announces Phase II Malignant Mesothelioma Results
Business Wire - March 23, 1999
BLOOMFIELD, N.J.--(BUSINESS WIRE)--March 23, 1999--
Data on ONCONASE as a single agent presented in Italy
On Friday, March 19, 1999, ALFACELL Corporation (NASDAQ: ACEL) presented the results of its Phase II clinical trial testing its flagship product Onconase in patie... (Read More)
| 
